Journal Alert - JOURNAL OF ATTENTION DISORDERS

Conclusion: There are not enough controlled clinical trials for showing the efficacy of atomoxetine for treatment of ADHD symptoms in autism. Although evidence suggests potential efficacy of atomoxetine, the current evidences are not conclusive. ======================================================================== *Pages: 641-654 (Article) *View Full Record: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Alerting&SrcApp=Alerting&DestApp=CCC&DestLinkType=FullRecord;KeyUT=CCC:000325419400002 *Order Full Text [ ] Title: Brain Cortical Thickness in ADHD: Age, Sex, and Clinical Correlations Authors: Montes, LGA; Alcantara, HP; Garcia, RBM; De La Torre, LB; Acosta, DA; Duarte, MG Source: *JOURNAL OF ATTENTION DISORDERS*, 17 (8):641-654; NOV 2013 Abstract: Objective: Longitudinal magnetic resonance imaging (MRI) studies have shown reduced cortical thickness (CT) in individuals with ADHD, but this abnormality disappears with age, suggesting developmental delay. However, cross-sectional MRI studies have shown reduced CT, suggesting abnormal development. The aim of this study was to compare whole-brain CT in male and female children, adolescents, and adults with ADHD with whole-brain CT in matched control participants. Method: MRI scans were performed on ADHD and control participants. Results: CT data revealed differences in right hemisphere (RH) only. Reduced CT was observed predominantly in the fro...
Source: Intelligent Insights on Intelligence Theories and Tests (aka IQ's Corner) - Category: Neurologists Source Type: blogs